Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ozturk BT et al. – Increased serum levels of VEGF and MCP–1 may act as a key regulator of DR and provide a potential tool for risk assessment in diabetic patients. Further studies that evaluate both vitreous and serum levels in various stages of DR are needed to provide a better understanding of the interaction between systemic and local inflammatory and angiogenic factors.

Related Articles

Glyceraldehyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopathy
Investigative Ophthalmology and Visual Science, 11/18/09    Relevance Score: 69%

Identification of independent risk factors for the development of diabetic retinopathy requiring treatment
Acta Ophthalmologica, 11/18/09    Relevance Score: 69%

Diabetic Retinopathy Screening Update
Clinical Diabetes, 10/19/09    Relevance Score: 69%

Retinopathy - screening recommendations
Australian Family Physician, 10/06/09    Relevance Score: 69%

Micronutrients and Diabetic Retinopathy: A Systematic Review
Ophthalmology, 11/10/09    Relevance Score: 67%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address